PBS Newshour: Cancer immunotherapy has life-saving powers — and limits http://www.pbs.org/newshour/bb/cancer-immunotherapy-life-saving-powers-limits/ The first segment features cancer survivor Melinda Welsh, an ONCS combination treatment patient, and lead investigator for ONCS, Dr. Alain Algazi. This PBS segment does not mention ONCS. But here lies an opportunity to understand the company's potential before the market does, IMO. Earlier coverage on The LA Times: http://oncosec.com/patients-perspective/